Fetal alcohol spectrum disorders (FASD) affect an estimated 2 to 5 percent of children nationwide, yet many go undiagnosed due to high assessment costs, long wait times, stigma, and limited trained providers. Few interventions exist for this population. In this presentation, Drs. Blake Gimbel and Jeffrey Wozniak—child psychologists and FASD researchers—will share details about their study testing an online neuropsychological screening tool designed to improve diagnostic access, especially in rural areas. They will outline the research, explain how families can participate, and discuss findings on choline as a brain-health intervention for young children with FASD. Audience questions on these and related topics will be welcomed.